P-168 Combination of gemcitabine plus cisplatin compared to non-gemcitabine and cisplatin regimens as neo-adjuvant treatment in liver transplant recipients with cholangiocarcinoma: Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022

M. Abdelrahim; A. Esmail; J. Xu; G. Umoru; H. Al-Rawi; A. Saharia

doi:10.1016/j.annonc.2022.04.258

P-168 Combination of gemcitabine plus cisplatin compared to non-gemcitabine and cisplatin regimens as neo-adjuvant treatment in liver transplant recipients with cholangiocarcinoma: Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022

M. Abdelrahim, A. Esmail, J. Xu, G. Umoru, H. Al-Rawi, A. Saharia

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	S309-S310
Journal	Annals of Oncology
Volume	33
DOIs	https://doi.org/10.1016/j.annonc.2022.04.258
State	Published - 2022

Access to Document

10.1016/j.annonc.2022.04.258

https://www.sciencedirect.com/science/article/pii/S0923753422009486

Cite this

Abdelrahim, M., Esmail, A., Xu, J., Umoru, G., Al-Rawi, H., & Saharia, A. (2022). P-168 Combination of gemcitabine plus cisplatin compared to non-gemcitabine and cisplatin regimens as neo-adjuvant treatment in liver transplant recipients with cholangiocarcinoma: Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022. Annals of Oncology, 33, S309-S310. https://doi.org/10.1016/j.annonc.2022.04.258

P-168 Combination of gemcitabine plus cisplatin compared to non-gemcitabine and cisplatin regimens as neo-adjuvant treatment in liver transplant recipients with cholangiocarcinoma: Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022. / Abdelrahim, M.; Esmail, A.; Xu, J. et al.
In: Annals of Oncology, Vol. 33, 2022, p. S309-S310.

Research output: Contribution to journal › Article › peer-review

Abdelrahim, M, Esmail, A, Xu, J, Umoru, G, Al-Rawi, H & Saharia, A 2022, 'P-168 Combination of gemcitabine plus cisplatin compared to non-gemcitabine and cisplatin regimens as neo-adjuvant treatment in liver transplant recipients with cholangiocarcinoma: Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022', Annals of Oncology, vol. 33, pp. S309-S310. https://doi.org/10.1016/j.annonc.2022.04.258

Abdelrahim M, Esmail A, Xu J, Umoru G, Al-Rawi H, Saharia A. P-168 Combination of gemcitabine plus cisplatin compared to non-gemcitabine and cisplatin regimens as neo-adjuvant treatment in liver transplant recipients with cholangiocarcinoma: Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022. Annals of Oncology. 2022;33:S309-S310. doi: 10.1016/j.annonc.2022.04.258

Abdelrahim, M. ; Esmail, A. ; Xu, J. et al. / P-168 Combination of gemcitabine plus cisplatin compared to non-gemcitabine and cisplatin regimens as neo-adjuvant treatment in liver transplant recipients with cholangiocarcinoma : Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022. In: Annals of Oncology. 2022 ; Vol. 33. pp. S309-S310.

@article{99bab29e68bf4314abd5a179e27a7d85,

title = "P-168 Combination of gemcitabine plus cisplatin compared to non-gemcitabine and cisplatin regimens as neo-adjuvant treatment in liver transplant recipients with cholangiocarcinoma: Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022",

author = "M. Abdelrahim and A. Esmail and J. Xu and G. Umoru and H. Al-Rawi and A. Saharia",

year = "2022",

doi = "10.1016/j.annonc.2022.04.258",

language = "English (US)",

volume = "33",

pages = "S309--S310",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - P-168 Combination of gemcitabine plus cisplatin compared to non-gemcitabine and cisplatin regimens as neo-adjuvant treatment in liver transplant recipients with cholangiocarcinoma

T2 - Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022, Barcelona, Spain, 29 June -2 July 2022

AU - Abdelrahim, M.

AU - Esmail, A.

AU - Xu, J.

AU - Umoru, G.

AU - Al-Rawi, H.

AU - Saharia, A.

PY - 2022

Y1 - 2022

U2 - 10.1016/j.annonc.2022.04.258

DO - 10.1016/j.annonc.2022.04.258

M3 - Article

SN - 0923-7534

VL - 33

SP - S309-S310

JO - Annals of Oncology

JF - Annals of Oncology

ER -